ヨーロッパの免疫測定ガンマカウンター市場 – 業界動向と2028年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの免疫測定ガンマカウンター市場 – 業界動向と2028年までの予測

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • Europe
  • 350 ページ
  • テーブル数: 222
  • 図の数: 49

>ヨーロッパの免疫測定-ガンマカウンター市場、製品タイプ別 (自動、手動/半自動)、ウェル (マルチウェル、シングルウェル)、アプリケーション別 (ラジオ免疫測定、核医学測定、その他)、病状別 (がんバイオマーカー、感染症、治療薬モニタリング、内分泌ホルモン、アレルギー、新生児スクリーニング、心臓マーカー、自己免疫疾患、その他)、購入モード別 (一括購入、レンタル購入)、エンドユーザー別 (研究室、病院、研究・学術機関、製薬・バイオテクノロジー企業、血液銀行、その他)、流通チャネル別 (直接入札、サードパーティ販売業者)、国別 (ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、ベルギー、トルコ、オーストリア、ノルウェー、ハンガリー、リトアニア、アイルランド、ポーランド、その他のヨーロッパ諸国) 業界動向と2028年までの予測。

ヨーロッパの免疫測定ガンマカウンター市場市場分析と洞察: ヨーロッパの免疫測定ガンマカウンター市場

ヨーロッパの免疫測定ガンマカウンター市場は、2021年から2028年の予測期間に市場が成長すると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に5.0%のCAGRで成長し、2028年までに2,551万米ドルに達すると分析しています。慢性疾患の有病率の増加と核医学の採用の増加は、予測期間における市場の需要を推進する主な原動力です。

免疫測定法は、抗体または抗原を使用して溶液中の高分子または小分子の存在または濃度を測定する生化学検査です。生化学検査は、「ガンマカウンター」と呼ばれる装置を使用して行われます。ガンマカウンターは、放射性核種から放出されるガンマ線を測定する機器です。サーベイメーターとは異なり、ガンマカウンターは放射性物質の小さなサンプルを測定するように設計されており、通常は複数のサンプルの自動測定と移動を行います。研究開発費の増加、医療費の増加、慢性疾患治療に対する患者の意識の高まりにより、市場には有利な成長機会がもたらされると予想されています。ただし、ガンマカウンターの高コストとガンマ線のリスクは、予測期間中の市場成長を抑制する要因になると予想されます。

免疫測定ガンマカウンター市場の需要は先進国と発展途上国の両方で増加しており、その背景にあるのは世界的な医療費の増加です。免疫測定ガンマカウンター市場は、先進技術製品の承認の増加と政府の支援の増加により成長しています。市場は、市場プレーヤーによる戦略的イニシアチブの増加により、予測期間中に成長するでしょう。

免疫測定ガンマカウンター市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

ヨーロッパの免疫測定ガンマカウンター市場ヨーロッパの免疫測定-ガンマカウンター市場の範囲と市場規模  

免疫測定ガンマカウンター市場は、製品タイプ、井戸、用途、病状、購入モード、エンドユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。 

  • 製品タイプに基づいて、ヨーロッパの免疫アッセイ-ガンマカウンター市場は、自動、手動/半自動に分類されます。2021年には、工場のリードタイムが短縮され、競争力が高まるため、自動化セグメントが市場を支配すると予想されます。
  • ウェルに基づいて、ヨーロッパの免疫測定ガンマカウンター市場は、マルチウェルとシングルウェルに分類されます。2021年には、正確な測定と、短期間でより高いスペクトルレベルを生成する能力により、マルチウェルセグメントが市場を支配すると予想されます。
  • 用途に基づいて、ヨーロッパの免疫測定ガンマカウンター市場は、ラジオ免疫測定、核医学測定、その他に分類されます。2021年には、ラジオ免疫測定が、高い特異性と感度により市場を支配すると予想されます。
  • 病状に基づいて、ヨーロッパの免疫アッセイ-ガンマカウンター市場は、がんバイオマーカー、感染症、治療薬モニタリング、内分泌ホルモン、アレルギー、新生児スクリーニング、心臓マーカー、自己免疫疾患、その他に分類されています。2021年には、がんバイオマーカーセグメントが、疾患メカニズムの研究と十分な特性評価により市場を支配すると予想されています。
  • 購入モードに基づいて、ヨーロッパの免疫アッセイガンマカウンター市場は、一括購入、レンタル購入に分類されます。2021年には、内部効率の向上とイノベーションにより、一括購入セグメントが市場を支配すると予想されます。
  • エンドユーザーに基づいて、ヨーロッパの免疫アッセイガンマカウンター市場は、研究所、病院、研究・学術機関、製薬・バイオテクノロジー企業、血液銀行、その他に分類されます。2021年には、再現性と客観性、リアルタイムモニタリングにより、研究所セグメントが市場を支配すると予想されます。
  • 流通チャネルに基づいて、ヨーロッパの免疫アッセイガンマカウンター市場は、直接販売とサードパーティの販売代理店に分割されています。2021年には、再エンゲージメント、コスト削減、独立した人材により、直接入札セグメントが市場を支配すると予想されます。

免疫測定ガンマカウンター市場の国別分析

免疫測定ガンマカウンター市場は分析されており、製品タイプ、井戸、用途、病状、購入モード、エンドユーザー、流通チャネルに基づいて市場規模の情報が提供されています。

免疫測定ガンマカウンター市場レポートで取り上げられている国は、フランス、英国、イタリア、ドイツ、スペイン、オランダ、ロシア、スイス、トルコ、オーストリア、ノルウェー、ハンガリー、リトアニア、アイルランド、ポーランド、その他のヨーロッパ諸国です。

ヨーロッパ地域の放射免疫測定セグメントは、高い特異性と感度により、2021年から2028年の予測期間に最高の成長率で成長すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

製品の承認と診断手順の新規性により、免疫測定ガンマカウンターの市場成長が促進されています。 

免疫測定ガンマカウンター市場では、バクテリオファージ療法産業の各国における成長、医薬品販売、進歩の影響、技術、OCD医薬品市場へのサポートによる規制シナリオの変化など、詳細な市場分析も提供しています。データは、2010年から2019年までの履歴期間について入手可能です。

競争環境とバクテリオファージ療法の市場シェア分析

免疫測定ガンマカウンター市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供された上記のデータポイントは、免疫測定ガンマカウンター市場に関連する会社の焦点にのみ関連しています。

ヨーロッパの免疫測定ガンマカウンター市場で事業を展開している主要企業としては、Hidex Oy、Perkin Elmer Inc、Berthold Technologies GmbH & Co. KG、ENERSYS Co. Ltd、Shinjin Medics Inc、LabLogic Systems Ltd などがあります。

世界中の企業によって多くの製品の発売や契約も開始されており、免疫測定ガンマカウンター市場も加速しています。

例えば、

  • 2021年7月、パーキンエルマー社は、革新的な製品を活用してインドでの事業展開をさらに拡大することを目指していると発表しました。新製品は、科学、製薬、食品検査など、さまざまな分野で発売される予定です。これにより、同社は世界的な存在感を拡大することができました。
  •  2020年11月、Berthold Technologies GmbH & C0.KGは、感染率を下げるために部分的なロックダウンを命じたことを発表しました。しかし、同社は政府の適切なガイドラインに従ってこの期間中も生産を継続し、確実な納品を顧客に保証しました。これにより、同社はパンデミックの間も需要を維持し、収益を上げることができます。

市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、免疫測定ガンマカウンター市場における企業市場が強化され、組織が免疫測定ガンマカウンターの提供を改善するメリットももたらされます。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Immunoassay-gamma counters market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product TYPE LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET APPLICATION COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. pestel analysis
    2. portes five forces
  5. REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS
    1. U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS
    2. EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
    3. JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
    4. CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
  6. Market Overview
    1. DRIVERS
      1. IncreASE IN Prevalence of chronic diseaseS
      2. PRODUCT APPROVAL
      3. IncreasE IN adoption of Nuclear Medicine
      4. Novelty in Diagnosis Procedures
      5. upgrading Gamma technology
    2. RESTRAINTS
      1. High Cost of gamma counter
      2. Risk of gamma radiation
      3. Stringent regulation of clinical use of gamma counter
      4. product recall
    3. Opportunities
      1. Growing Research and development expenditure
      2. IncreasE IN healthcare expenditure
      3. Rise in patients awareness towards chronic disease treatment
    4. CHALLENGES
      1. challenges in using gamma counter
      2. Lack of skilled and certified professionals
  7. IMPACT OF COVID-19 ON EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET
    1. IMPACT ON THE PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. STRATEGIC INITIATIVES BY MANUFACTURERS
    5. CONCLUSION
  8. Europe IMMUNOASSAY-GAMMA COUNTERS maRKET, BY PRODUCT TYPE
    1. overview
    2. AUTOMATED
      1. Radioimmunoassays
        1. RIA
        2. IRMA
      2. Nuclear Medicine Assays
        1. GFR (Glomerular FILTRATION RATE)
        2. Gamma glutamyl transferase (ggt)
        3. red cell mass and plasma volume test
        4. THE SCHILLING TEST
        5. others
      3. OTHERS
    3. MANUAL/SEMI-AUTOMATED
      1. Radioimmunoassays
        1. RIA
        2. IRMA
      2. Nuclear Medicine Assays
        1. GFR (Glomerular FILTRATION RATE)
        2. Gamma glutamyl transferase (ggt)
        3. red cell mass and plasma volume test
        4. THE SCHILLING TEST
        5. others
      3. OTHERS
  9. Europe immunoassay-gamma counters market, BY well
    1. overview
    2. MULTI-WELL
    3. SINGLE-WELL
  10. Europe immunoassay-gamma counters market, BY APPLICATION
    1. overview
    2. RADIO IMMUNOASSAYS
      1. RIA
      2. IRMA
    3. NUCLEAR MEDICINE ASSAY
      1. GFR (GLOMERULAR FILTRATION RATE)
      2. gamma-glutamyl transferase
      3. red cell mass and plasma volume test
      4. THE SCHILLING TEST
      5. others
    4. OTHERS
  11. Europe immunoassay-gamma counters market, BY DISEASE CONDITION
    1. overview
    2. cancer biomarkers
      1. CARBOHYDRATE ANTIGEN 125 (CA125)
      2. CARBOHYDRATE ANTIGEN 19-9
      3. caRCINO EMBRYONIC ANTIGEN
      4. alpha-fetoprotein
      5. others
    3. infectious diseases
    4. therapeutic drug monitoring
    5. endocrine hormones
    6. ALLERGY
    7. NEONATAL SCREENING
    8. cardiac markers
    9. autoimmune disease
    10. others
  12. Europe immunoassay-gamma counters market, BY purchase mode
    1. overview
    2. Outright purchase
    3. rental purchase
  13. Europe Immunoassay-gamma Counters Market, BY distribution channel
    1. overview
    2. DIRECT TENDER
    3. THIRD PARTY DISTRIBUTORS
  14. Europe Immunoassay-gamma Counters Market, BY end user
    1. overview
    2. HOSPITALS
    3. LABORATORY
    4. BLOOD BANKS
    5. RESEARCH AND ACADEMIC INSTITUTES
    6. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    7. OTHERS
  15. EUROPE Immunoassay-Gamma Counters MARKET, by geography
    1. EUROPE
      1. GERMANY
      2. U.K.
      3. France
      4. ITALY
      5. SPAIN
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. BELGIUM
      10. TURKEY
      11. REst of europe
  16. EUROPE Immunoassay-Gamma counters Market: COMPANY landscape
    1. company share analysis: Europe
  17. swot analysis
  18. company profile
    1. perkinelmer inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Company Share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. bRETHOLD TECHNOLOGIES gMBH & CO.KG
      1. COMPANY SNAPSHOT
      2. Company Share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. LabLogic Systems Ltd.
      1. COMPANY SNAPSHOT
      2. Company Share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. SHIN JIN MEDICS INC.
      1. COMPANY SNAPSHOT
      2. Company Share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. hidex oy
      1. COMPANY SNAPSHOT
      2. Company Share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. LABORATORY TECHNOLOGIES. inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. ENERSYS, Co.Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. MIRION TECHNOLOGIES (CAPINTEC),INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  19. questionnaire
  20. related reports

表のリスト

TABLE 1 Number of people with diabetes (Million) among ages 20–79 years

TABLE 2 Healthcare expenditure in asia-pacific

TABLE 3 Europe immunoassay-gamma counters market, By PRODUCT TYPE, 2015-2028 (USD Million)

TABLE 4 Europe AUTOMATED in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 5 Europe automated in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)

TABLE 6 Europe Radioimmunoassays in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)

TABLE 7 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)

TABLE 8 Europe manual/semi-automated in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 9 Europe manual/semi-automated in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)

TABLE 10 Europe radioimmunoassay in immunoassay-gamma counters market, By product type, 2015-2028 (USD MILLION)

TABLE 11 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 12 Europe immunoassay-gamma counters market, By WELL, 2015-2028 (USD Million)

TABLE 13 Europe multi-well in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 14 Europe single-well in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 15 Europe immunoassay-gamma counters market, By APPLICATION, 2015-2028 (USD Million)

TABLE 16 Europe RADIO IMMUNOASSAYS in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 17 Europe RADIO IMMUNOASSAYS in immunoassay-gamma counters market, By application, 2015-2028 (USD MILLION)

TABLE 18 Europe nuclear medicine assay in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 19 Europe NUCLEAR MEDICINE ASSAYS in immunoassay-gamma counters market, By application, 2015-2028 (USD MILLION)

TABLE 20 Europe others in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 21 Europe immunoassay-gamma counters market, By disease condition, 2015-2028 (USD Million)

TABLE 22 Europe cancer biomarkers in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 23 Europe cancer biomarkers in immunoassay-gamma counters market, By disease condition, 2015-2028 (USD MILLION)

TABLE 24 Europe infectious diseases in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 25 Europe therapeutic drug monitoring in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 26 Europe endocrine hormones in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 27 Europe ALLERGY in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 28 Europe neonatal screening in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 29 Europe cardiac makers in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 30 Europe auto immune disease in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 31 Europe others in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 32 Europe immunoassay-gamma counters market, By purchase mode, 2015-2028 (USD Million)

TABLE 33 Europe Outright purchase in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 34 Europe rental purchase in immunoassay-gamma counters market, By Region, 2015-2028 (USD MILLION)

TABLE 35 Europe immunoassay-gamma counters Market, By distribution channel, 2015-2028 (USD million)

TABLE 36 Europe Direct Tender in Immunoassay-Gamma Counters Market, By Distribution Channel, 2015-2028 (USD million)

TABLE 37 Europe Third Party Distributors in Immunoassay-Gamma Counters Market, By Distribution Channel, 2015-2028 (USD million)

TABLE 38 Europe immunoassay-gamma counters Market, By end user, 2015-2028 (USD million)

TABLE 39 Europe Hospitals in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)

TABLE 40 Europe laboratory in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)

TABLE 41 Europe blood banks in Immunoassay-Gamma Counters Market, By End User, 20152028 (USD million)

TABLE 42 Europe research and academic institutes in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)

TABLE 43 Europe pharmaceutical and biotechnology companies in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)

TABLE 44 others in Immunoassay-Gamma Counters Market, By End User, 2015-2028 (USD million)

TABLE 45 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By COUNTRY, 2015-2028 (USD Million)

TABLE 46 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 47 EUROPE AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 48 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 49 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 50 EUROPE MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 51 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 52 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 53 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 54 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 55 EUROPE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 56 EUROPE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 57 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 58 EUROPE Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 59 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 60 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 61 EUROPE IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 62 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 63 GERMANY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 64 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 65 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 66 GERMANY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 67 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 68 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 69 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 70 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 71 GERMANY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 72 GERMANY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 73 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 74 GERMANY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 75 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 76 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 77 GERMANY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 78 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 79 U.K. AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 80 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 81 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 82 U.K. MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 83 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 84 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 85 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 86 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 87 U.K. RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 88 U.K. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 89 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 90 U.K. Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 91 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 92 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 93 U.K. IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 94 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 95 FRANCE AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 96 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 97 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 98 FRANCE MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 99 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 100 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 101 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 102 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 103 FRANCE RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 104 FRANCE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 105 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 106 FRANCE Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 107 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 108 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 109 FRANCE IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 110 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 111 ITALY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 112 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 113 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 114 ITALY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 115 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 116 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 117 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 118 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 119 ITALY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 120 ITALY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 121 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 122 ITALY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 123 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 124 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 125 ITALY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 126 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 127 SPAIN AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 128 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 129 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 130 SPAIN MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 131 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 132 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 133 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 134 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 135 SPAIN RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 136 SPAIN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 137 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 138 SPAIN Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 139 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 140 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 141 SPAIN IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 142 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 143 NETHERLANDS AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 144 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 145 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 146 NETHERLANDS MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 147 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 148 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 149 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 150 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 151 NETHERLANDS RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 152 NETHERLANDS NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 153 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 154 NETHERLANDS Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 155 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 156 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 157 NETHERLANDS IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 158 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 159 RUSSIA AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 160 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 161 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 162 RUSSIA MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 163 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 164 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 165 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 166 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 167 RUSSIA RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 168 RUSSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 169 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 170 RUSSIA Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 171 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 172 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 173 RUSSIA IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 174 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 175 SWITZERLAND AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 176 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 177 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 178 SWITZERLAND MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 179 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 180 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 181 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 182 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 183 SWITZERLAND RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 184 SWITZERLAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 185 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 186 SWITZERLAND Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 187 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 188 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 189 SWITZERLAND IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 190 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 191 BELGIUM AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 192 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 193 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 194 BELGIUM MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 195 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 196 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 197 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 198 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 199 BELGIUM RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 200 BELGIUM NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 201 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 202 BELGIUM Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 203 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 204 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 205 BELGIUM IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 206 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

TABLE 207 TURKEY AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 208 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 209 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 210 TURKEY MANUAL/SEMI-AUTOMAted in IMMUNOASSAY-GAMMA COUNTERS Market, By product type, 2015-2028 (USD MILLION)

TABLE 211 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By product Type, 2015-2028 (USD Million)

TABLE 212 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Product TYPE, 2015-2028 (USD Million)

TABLE 213 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By WELL, 2015-2028 (USD Million)

TABLE 214 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD MILLION)

TABLE 215 TURKEY RADIOimmunoassays in IMMUNOASSAY-GAMMA COUNTERS Market, By Application, 2015-2028 (USD Million)

TABLE 216 TURKEY NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, By Application, 2015-2028 (USD Million)

TABLE 217 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Disease Condition, 2015-2028 (USD Million)

TABLE 218 TURKEY Cancer biomarkers in IMMUNOASSAY-GAMMA COUNTERS Market, By disease condition, 2015-2028 (USD Million)

TABLE 219 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Purchase mode, 2015-2028 (USD Million)

TABLE 220 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By END USER, 2015-2028 (USD Million)

TABLE 221 TURKEY IMMUNOASSAY-GAMMA COUNTERS Market, By Distribution Channel, 2015-2028 (USD Million)

TABLE 222 Rest of Europe IMMUNOASSAY-GAMMA COUNTERS Market, By Product type, 2015-2028 (USD Million)

図表一覧

FIGURE 1 Europe IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION

FIGURE 2 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION

FIGURE 3 Europe Immunoassay-gamma counters market: DROC ANALYSIS

FIGURE 4 Europe Immunoassay-gamma counters market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Immunoassay-gamma counters market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Immunoassay-gamma counters market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Immunoassay-gamma counters market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE Immunoassay-gamma counters market: APPLICATION COVERAGE GRID

FIGURE 10 EUROPE IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Immunoassay-gamma counters market: SEGMENTATION

FIGURE 12 Increase in Prevalence of chronic diseaseS AND Growing use of Nuclear medicine is EXPECTED TO DRIVE THE Europe Immunoassay-gamma counters market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 AUTOMATED is expected to account for the largest share of the Europe IMMUNOASSAY-GAMMA COUNTERS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF Europe immunoassay-gamma COUNTERS MARKET

FIGURE 15 Health Spending by Major Sources of Funds

FIGURE 16 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, 2020

FIGURE 17 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, 2021-2028 (USD Million)

FIGURE 18 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 19 Europe immunoassay-gamma counters market : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 Europe immunoassay-gamma counters market : BY WELL, 2020

FIGURE 21 Europe immunoassay-gamma counters market : BY WELL, 2021-2028 (USD Million)

FIGURE 22 Europe immunoassay-gamma counters market : BY WELL, CAGR (2021-2028)

FIGURE 23 Europe immunoassay-gamma counters market : BY WELL, LIFELINE CURVE

FIGURE 24 Europe immunoassay-gamma counters market : BY application, 2020

FIGURE 25 Europe immunoassay-gamma counters market : BY application, 2021-2028 (USD Million)

FIGURE 26 Europe immunoassay-gamma counters market : BY application, CAGR (2021-2028)

FIGURE 27 Europe immunoassay-gamma counters market : BY application, LIFELINE CURVE

FIGURE 28 Europe immunoassay-gamma counters market : BY disease condition, 2020

FIGURE 29 Europe immunoassay-gamma counters market: BY disease condition, 2021-2028 (USD Million)

FIGURE 30 Europe immunoassay-gamma counters market : BY disease condition, CAGR (2021-2028)

FIGURE 31 Europe immunoassay-gamma counters market : BY disease condition, LIFELINE CURVE

FIGURE 32 Europe immunoassay-gamma counters market : BY purchase mode, 2020

FIGURE 33 Europe immunoassay-gamma counters market : BY purchase mode, 2021-2028 (USD Million)

FIGURE 34 Europe immunoassay-gamma counters market : BY purchase mode, CAGR (2021-2028)

FIGURE 35 Europe immunoassay-gamma counters market : BY purchase mode, LIFELINE CURVE

FIGURE 36 Europe immunoassay-gamma counters market : BY distribution channel, 2020

FIGURE 37 Europe immunoassay-gamma counters market : BY distribution channel, 2021-2028 (USD Million)

FIGURE 38 Europe immunoassay-gamma counters market : BY distribution channel, CAGR (2021-2028)

FIGURE 39 Europe immunoassay-gamma counters market : BY distribution channel, LIFELINE CURVE

FIGURE 40 Europe immunoassay-gamma counters market : BY end user, 2020

FIGURE 41 Europe immunoassay-gamma counters market : BY end user, 2021-2028 (USD Million)

FIGURE 42 Europe immunoassay-gamma counters market : BY end user, CAGR (2021-2028)

FIGURE 43 Europe immunoassay-gamma counters market : BY end user, LIFELINE CURVE

FIGURE 44 EUROPE Immunoassay-gamma counters market : SNAPSHOT (2020)

FIGURE 45 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2020)

FIGURE 46 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2021 &2028)

FIGURE 47 EUROPE Immunoassay-gamma counters market : BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE Immunoassay-gamma counters market : BY PRODUCT TYPE (2021-2028)

FIGURE 49 Europe Immunoassay-gamma counters market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。